Brief: Harrow Announces First Quarter 2023 Financial Results
May 11 (Reuters) - Harrow Health Inc HROW.O :
* HARROW ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
* HARROW HEALTH INC Q1 REVENUE $26.1 MILLION
* HARROW HEALTH INC - WE ARE REAFFIRMING OUR 2023 GUIDANCE
OF $135
MILLION TO $143 MILLION IN NET REVENUES AND $44 MILLION TO $50
MILLION IN ADJUSTED EBITDA.
Source text for Eikon: ID:nBw2XDnxka
Further company coverage: HROW.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates